tiprankstipranks
Trending News
More News >
Viveve Medical (VIVE)
OTHER OTC:VIVE
US Market

Viveve Medical (VIVE) Ratios

Compare
512 Followers

Viveve Medical Ratios

VIVE's free cash flow for Q3 2022 was $0.32. For the 2022 fiscal year, VIVE's free cash flow was decreased by $ and operating cash flow was $-2.78. See a summary of the company’s cash flow.
Ratios
TTM
Dec 21Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio
4.91 3.05 3.52--
Quick Ratio
4.58 2.27 2.75--
Cash Ratio
4.23 1.55 2.11--
Solvency Ratio
-1.93 -2.07 -4.36--
Operating Cash Flow Ratio
-2.84 -3.61 -4.95--
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00--
Net Current Asset Value
$ 11.39M$ 3.19M$ 11.73M--
Leverage Ratios
Debt-to-Assets Ratio
0.21 0.35 0.16--
Debt-to-Equity Ratio
0.36 0.84 0.26--
Debt-to-Capital Ratio
0.26 0.46 0.20--
Long-Term Debt-to-Capital Ratio
0.25 0.41 0.19--
Financial Leverage Ratio
1.72 2.38 1.63--
Debt Service Coverage Ratio
-19.89 -20.00 -8.15--
Interest Coverage Ratio
-21.55 -20.32 -6.88--
Debt to Market Cap
1.19K <0.01 <0.01--
Interest Debt Per Share
0.63 4.30 68.96--
Net Debt to EBITDA
0.70 0.04 0.30--
Profitability Margins
Gross Profit Margin
9.65%5.40%15.47%--
EBIT Margin
-323.23%-376.38%-571.72%--
EBITDA Margin
-305.51%-337.56%-467.17%--
Operating Profit Margin
-335.40%-337.56%-455.87%--
Pretax Profit Margin
-338.80%-392.99%-638.02%--
Net Profit Margin
-342.78%-387.64%-711.42%--
Continuous Operations Profit Margin
-342.78%-399.98%-647.57%--
Net Income Per EBT
101.18%98.64%111.50%--
EBT Per EBIT
101.01%116.42%139.96%--
Return on Assets (ROA)
-85.00%-127.71%-173.18%--
Return on Equity (ROE)
-199.88%-304.55%-282.79%--
Return on Capital Employed (ROCE)
-100.81%-148.97%-144.83%--
Return on Invested Capital (ROIC)
-100.93%-145.40%-159.42%--
Return on Tangible Assets
-85.00%-127.71%-173.18%--
Earnings Yield
-2183112.68%-0.03%-0.30%--
Efficiency Ratios
Receivables Turnover
11.70 7.12 4.17--
Payables Turnover
3.92 5.88 3.45--
Inventory Turnover
3.94 1.59 1.14--
Fixed Asset Turnover
4.14 1.99 2.16--
Asset Turnover
0.25 0.33 0.24--
Working Capital Turnover Ratio
0.49 0.45 0.28--
Cash Conversion Cycle
30.68 218.41 301.33--
Days of Sales Outstanding
31.18 51.30 87.43--
Days of Inventory Outstanding
92.54 229.15 319.63--
Days of Payables Outstanding
93.04 62.04 105.73--
Operating Cycle
123.72 280.45 407.06--
Cash Flow Ratios
Operating Cash Flow Per Share
-1.28 -9.68 -250.32--
Free Cash Flow Per Share
-1.32 -10.18 -259.03--
CapEx Per Share
0.05 0.50 8.71--
Free Cash Flow to Operating Cash Flow
1.04 1.05 1.03--
Dividend Paid and CapEx Coverage Ratio
-28.24 -19.51 -21.32--
Capital Expenditure Coverage Ratio
-28.24 -19.51 -28.74--
Operating Cash Flow Coverage Ratio
-2.41 -2.60 -7.35--
Operating Cash Flow to Sales Ratio
-2.00 -2.78 -4.76--
Free Cash Flow Yield
-310888.32%-0.02%-0.21%--
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -3.48K -336.54--
Price-to-Sales (P/S) Ratio
<0.01 13.50K 2.39K--
Price-to-Book (P/B) Ratio
<0.01 10.60K 951.68--
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -4.62K -486.43--
Price-to-Operating Cash Flow Ratio
>-0.01 -4.85K -503.35--
Price-to-Earnings Growth (PEG) Ratio
>-0.01 36.12 4.41--
Price-to-Fair Value
<0.01 10.60K 951.68--
Enterprise Value Multiple
0.70 -4.00K -512.20--
Enterprise Value
-13.81M 73.96B 15.71B--
EV to EBITDA
0.70 -4.00K -512.20--
EV to Sales
-2.15 13.50K 2.39K--
EV to Free Cash Flow
1.04 -4.62K -486.15--
EV to Operating Cash Flow
1.07 -4.85K -503.06--
Tangible Book Value Per Share
1.49 4.43 132.40--
Shareholders’ Equity Per Share
1.49 4.43 132.40--
Tax and Other Ratios
Effective Tax Rate
-0.01 0.01 -0.12--
Revenue Per Share
0.64 3.48 52.63--
Net Income Per Share
-2.18 -13.50 -374.40--
Tax Burden
1.01 0.99 1.12--
Interest Burden
1.05 1.04 1.12--
Research & Development to Revenue
1.50 0.94 1.31--
SG&A to Revenue
0.00 0.00 0.00--
Stock-Based Compensation to Revenue
0.59 0.48 0.37--
Income Quality
0.58 0.70 0.73--
Currency in USD